Fibrolamellar Carcinoma

general

A distinctive type of liver cell carcinoma that arises in non-cirrhotic livers and is seen predominantly in young patients. The tumor cells are polygonal and deeply eosinophilic, and are embedded in a fibrous stroma. The prognosis is similar to classical hepatocellular carcinoma that arises in non-cirrhotic livers, and better than hepatocellular carcinoma that arises in cirrhotic livers.

59

Centers

83

Active Trials

$7M

Cancer Funding

Specific Cancer Types(2)

Top Centers for Fibrolamellar Carcinoma(59)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
71.4
2
High-Volume Research Center
71.4
3
NCI Comprehensive
Active Research Program
68.0
4
NCI Comprehensive
Active Research Program
68.0
5
NCI Comprehensive
Active Research Program
68.0
6
NCI Comprehensive
Active Research Program
68.0
7
NCI Clinical
Active Research Program
68.0
8
NCI Comprehensive
Active Research Program
68.0
9
Active Research Program
68.0
10
NCI Comprehensive
Active Research Program
64.0
11
NCI Comprehensive
Active Research Program
47.4
12
NCI Comprehensive
Active Research Program
47.4
13
NCI Comprehensive
Active Research Program
47.4
14
NCI Comprehensive
Active Research Program
47.4
15
NCI Comprehensive
Active Research Program
47.4
16
NCI Comprehensive
Active Research Program
47.4
17
NCI Comprehensive
Active Research Program
47.4
18
NCI Comprehensive
Active Research Program
47.4
19
NCI Comprehensive
Active Research Program
47.4
20
NCI Comprehensive
Active Research Program
47.4
21
NCI Comprehensive
Active Research Program
47.4
2247.4
23
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
47.4
24
NCI Comprehensive
Active Research Program
47.4
25
NCI Comprehensive
Active Research Program
47.4
26
NCI Clinical
Active Research Program
47.4
27
NCI Comprehensive
Active Research Program
47.4
28
NCI Comprehensive
Active Research Program
47.4
29
Active Research Program
47.4
30
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
47.4
31
NCI Comprehensive
Active Research Program
47.4
32
Active Research Program
47.4
33
NCI Comprehensive
Active Research Program
47.4
34
NCI Clinical
Active Research Program
47.4
35
NCI Comprehensive
Active Research Program
47.4
36
NCI Comprehensive
Active Research Program
47.4
37
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
47.4
38
Active Research Program
47.4
39
NCI Clinical
Active Research Program
47.4
40
NCI Comprehensive
Active Research Program
47.4
41
Active Research Program
47.4
42
NCI Comprehensive
Active Research Program
47.4
4347.4
44
Active Research Program
47.4
45
Active Research Program
47.4
46
Active Research Program
47.4
47
Active Research Program
47.4
48
Active Research Program
47.4
49
Active Research Program
47.4
50
Active Research Program
47.4
51
Active Research Program
47.4
5247.4
53
Active Research Program
47.4
54
Active Research Program
47.4
55
Active Research Program
47.4
56
Active Research Program
47.4
57
NCI Comprehensive
Active Research Program
46.7
58
NCI Comprehensive
Active Research Program
46.1
59
NCI Comprehensive
Active Research Program
45.5

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →